ArticleAnnals of translational medicine2021

A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909).

Yan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.